Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Clearside Biomedi
(NQ:
CLSD
)
1.190
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Clearside Biomedi
< Previous
1
2
3
4
5
Next >
Clearside Biomedical's Investigational Drug For Vision Loss Hits Primary Goals In Mid-Stage Study
October 09, 2024
Clearside Biomedical's CLS-AX Phase 2b trial for wet AMD met primary and secondary endpoints, showing stable vision and reduced injection frequency by 84% over 24 weeks, with no serious adverse events...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 09, 2024
Via
Benzinga
CLSD Stock Earnings: Clearside Biomedical Beats EPS, Misses Revenue for Q2 2024
August 12, 2024
CLSD stock results show that Clearside Biomedical beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Why Is Clearside Biomedical Stock Gaining Today?
June 25, 2024
Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer rates CLSD Outperform with a $5 target, citing its innovative SCS...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 22, 2024
Via
Benzinga
Clearside Biomedical: Q4 Earnings Insights
March 12, 2024
Via
Benzinga
Preview: Clearside Biomedical's Earnings
March 11, 2024
Via
Benzinga
Clearside Biomedical: Q3 Earnings Insights
November 13, 2023
Via
Benzinga
Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying
May 16, 2024
Via
Benzinga
CLSD Stock Earnings: Clearside Biomedical Misses EPS, Misses Revenue for Q1 2024
May 09, 2024
CLSD stock results show that Clearside Biomedical missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
May 09, 2024
Via
Benzinga
3 Penny Stocks That Insiders Are Buying
May 07, 2024
Penny stocks are a risky business but following the insiders to your next trade can alleviate some of the risks; these are the three hottest insider buys.
Via
MarketBeat
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
April 22, 2024
Via
Benzinga
Clearside Biomedical's Earnings: A Preview
November 10, 2023
Via
Benzinga
7 Top Stocks Under $7
April 11, 2024
Stocks under $7 have greater potential for substantial gains because they start off with lower valuations. Here are some of the best now.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 27, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 11, 2024
Via
Benzinga
Earnings Scheduled For March 12, 2024
March 12, 2024
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.
Via
Benzinga
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
February 25, 2024
Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 20, 2024
Via
Benzinga
Top 5 Health Care Stocks That May Crash This Month
January 22, 2024
As of Jan. 22, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via
Benzinga
Ocular Gene Therapy: Regenxbio Data Shows Consistent Preservation Of Visual Acuity, Retinal Thickness
January 17, 2024
Regenxbio's latest trial data on ABBV-RGX-314 reveal 80% reduction in injection rate, 50% injection-free, and no intraocular inflammation.
Via
Benzinga
Over $2M Bet On Community Health Systems? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
November 02, 2023
The Dow Jones closed higher by over 200 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Cheap Stocks to Buy Under $1 in October 2023
October 26, 2023
If you want extreme returns and can handle the prospects of utterly devastating losses, these cheap stocks under $1 might entice.
Via
InvestorPlace
Earnings Scheduled For November 13, 2023
November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Via
Benzinga
Week In Review: QYuns Plans Hong Kong IPO For Autoimmune/Allergic Disease Portfolio
October 07, 2023
Jiangsu QYuns Therapeutics filed for a Hong Kong IPO to underwrite development of its portfolio of clinical stage biologic antibody drugs for autoimmune and allergic diseases. Meanwhile, Biogen...
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Clearside Biomedical And 3 Other Stocks Under $3 Insiders Are Buying
October 05, 2023
The Dow Jones closed higher by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 27, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
June 14, 2023
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.